Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy
- PMID: 31538314
- DOI: 10.1007/s40618-019-01116-4
Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy
Abstract
Purpose: Immunohistochemistry of orbital tissues offers a correlation between the microscopic changes and macroscopic clinical manifestation of Graves' orbitopathy (GO). Summarizing the participation of different molecules will help us to understand the pathogenesis of GO.
Methods: The pertinent and current literature on immunohistochemistry of human orbital tissue in GO was reviewed using the NCBI PubMed database.
Results: 33 articles comprising over 700 orbital tissue samples were included in this review. The earliest findings included the demonstration of HLA-DR and T cell (to a lesser extent B cell) markers in GO orbital tissues. Subsequent investigators further contributed by characterizing cellular infiltration, confirming the presence of HLA-DR and TSHR, as well as revealing the participation of cytokines, growth factors, adhesion molecules and miscellaneous substances. HLA-DR and TSHR are over-expressed in orbital tissues of GO patients. The inflammatory infiltration mainly comprises CD4 + T cells and macrophages. Cytokine profile suggests the importance of Th1 (especially in early active phase) and Th17 immunity in the pathogenesis of GO. Upregulation of proinflammatory/profibrotic cytokines, adhesion molecules and growth factors finally culminate in activation of orbital fibroblasts and perpetuation of orbital inflammation. The molecular status of selected parameters correlates with the clinical presentation of GO.
Conclusion: Further investigation is warranted to define precisely the role of different molecules and ongoing search for new players yet to be discovered is also important. Unfolding the molecular mechanisms behind GO will hopefully provide insights into the development of novel therapeutic strategies and optimize our clinical management of the disease.
Keywords: Cytokine; Graves’ orbitopathy; Human leukocyte antigen; Immunohistochemistry; Orbital tissue; TSH receptor.
Similar articles
-
An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' Orbitopathy.Thyroid. 2022 Mar;32(3):283-293. doi: 10.1089/thy.2021.0464. Epub 2022 Jan 11. Thyroid. 2022. PMID: 34779257
-
Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.Exp Eye Res. 2016 Jan;142:83-91. doi: 10.1016/j.exer.2015.02.007. Exp Eye Res. 2016. PMID: 26675405 Review.
-
Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen.Endocrinology. 2016 Apr;157(4):1673-82. doi: 10.1210/en.2015-1829. Epub 2016 Feb 12. Endocrinology. 2016. PMID: 26872090
-
Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathy.Folia Histochem Cytobiol. 2020;58(1):37-45. doi: 10.5603/FHC.a2020.0003. Epub 2020 Mar 16. Folia Histochem Cytobiol. 2020. PMID: 32176314
-
Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.Front Endocrinol (Lausanne). 2021 Apr 1;12:648732. doi: 10.3389/fendo.2021.648732. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33868176 Free PMC article. Review.
Cited by
-
Elastin as a Novel Extracellular Matrix From Aberrant HDAC4 Expression in PDGF-BB-Induced Orbital Fibroblasts From Graves' Ophthalmopathy Patients.Invest Ophthalmol Vis Sci. 2025 Jul 1;66(9):30. doi: 10.1167/iovs.66.9.30. Invest Ophthalmol Vis Sci. 2025. PMID: 40643339 Free PMC article.
-
Management of Graves Thyroidal and Extrathyroidal Disease: An Update.J Clin Endocrinol Metab. 2020 Dec 1;105(12):3704-20. doi: 10.1210/clinem/dgaa646. J Clin Endocrinol Metab. 2020. PMID: 32929476 Free PMC article. Review.
-
Thyrotropin receptor antibodies and Graves' orbitopathy.J Endocrinol Invest. 2021 Apr;44(4):703-712. doi: 10.1007/s40618-020-01380-9. Epub 2020 Aug 4. J Endocrinol Invest. 2021. PMID: 32749654 Free PMC article. Review.
-
Mycophenolate Mofetil (CellCept®) in Combination With Low Dose Prednisolone in Moderate to Severe Graves' Orbitopathy.Front Med (Lausanne). 2022 Feb 11;9:788228. doi: 10.3389/fmed.2022.788228. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35223896 Free PMC article.
-
IgG4 as a Biomarker in Graves' Orbitopathy.Mediators Inflamm. 2021 Jun 10;2021:5590471. doi: 10.1155/2021/5590471. eCollection 2021. Mediators Inflamm. 2021. PMID: 34220335 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
